mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy (2008)
- Authors:
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU
- Unidades: FCF; HU
- Subjects: EXPRESSÃO GÊNICA; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2008
- Source:
- Título: Clinical Chemistry
- ISSN: 0009-9147
- Volume/Número/Paginação/Ano: v.54, n.6, supl., p.A150 res.D-21, 2008
- Conference titles: AACC Annual Meeting
-
ABNT
ARAZI, Simone Sorkin et al. mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 16 fev. 2026. , 2008 -
APA
Arazi, S. S., Genvigir, F. D. V., Willrich, M. A. V., Hirata, M. H., Oliveira, R., Dorea, E. L., et al. (2008). mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Oliveira R, Dorea EL, Bernik MMS, Hirata RDC. mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. 2008 ;54( 6): A150 res.D-21.[citado 2026 fev. 16 ] -
Vancouver
Arazi SS, Genvigir FDV, Willrich MAV, Hirata MH, Oliveira R, Dorea EL, Bernik MMS, Hirata RDC. mRNA expression of SREBF1, SREBF2 and SCAP transcription factors in peripheral mononuclear cells is modulated by atorvastatin therapy. Clinical Chemistry. 2008 ;54( 6): A150 res.D-21.[citado 2026 fev. 16 ] - Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Association between polymorphism of the hepatic uptake transporter SLCO1B1 and reduced atrovastatin response
- Scavenger receptor class B type I polymorphisms and its relation with serum lipids profile and response to atorvastatin in Brazilian individuals
- CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
- Estudo da expressão gênica e polimorfismos da CYP3A5 em indivíduos hipercolesterolêmicos tratados com atorvastatina
- Variants in S1P and ABCG1 genes are novel independent risk factors for dyslipidemia
- Efeito da atorvastatina sobre os genes SREBF1, SREBF2 e SCAP em pacientes hipercolesterolêmicos
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
